Henningfield JE, Ashworth J, Gerlach KK, Simone B, Schnoll SH Preventive Medicine, 128:10582, 2019. Special Issue on Opioids Addiction and Pain, 2019. Pain and addiction are complex disorders with many…
Henningfield JE, Fant RV, Wang DW Psychopharmacology (Berl). 235(2):573–589, 2018. View Publication…
Prozialeck WC, Avery BA, Boyer EW, Grundmann O, Henningfield JE, Kruegel AC, McMahon LR, McCurdy CR, Swogger MT, Veltri CA, Singh D. The International Journal on Drug Policy 70:70–77, 2019…
Singh D, Brown PN, Cinosi E, Corazza O, Henningfield JE, Garcia-Romeu A, McCurdy CR, McMahon LR, Prozialeck WC, Smith KE, Swogger MT,Veltri C, Walsh Z, Grundmann O Frontiers in Psychiatry,…
Henningfield JE, Swogger MT, Walsh Z., Kruegel AC, Grundmann O, Garcia- Romeu A, Raffa RB, Griffiths RR, Brown P February 8, 2018 View PDF…
Henningfield JE, Swogger MT, Walsh Z, Kruegel AC, Grundmann O, Garcia-Romeu A, Raffa RB, Griffiths RR, Brown P June 12, 2018 Dear Leader McConnell, Leader Schumer, Speaker Ryan, and Leader…
Coker A, Yazar-Klosinski B, Emerson A, Doblin R, Coe M, Henningfield JA If MDMA is approved for therapeutic use by the FDA, then it must be removed from Schedule I…
Chair/Speaker David Heal, PhD, DSc, FRSC, FBPhS, Executive Director, DevelRx Ltd. Speakers Jack Henningfield, PhD, Vice President, Research, Health Policy, and Abuse Liability, Pinney Associates Charles France, PhD, Robert A….